Flahy is the clinical intelligence layer for personalized care—combining genomics with health and clinical context to guide lifestyle and treatment decisions.
Biology is becoming digitized — genomics, biomarkers, imaging, and longitudinal signals are increasingly available. Flahy's clinical intelligence:
Integrates genomics with broader health and clinical context.
Standardizes how and when genomic insights are used.
Delivers actionable outputs across health, nutrition, and treatment decisions.
Built for scalable deployment across healthcare and wellness ecosystems.
One Unified Genomics Platform For Consumer & Clinical Care
Flahy’s proprietary digital biology platform processes genetic data for preventive and precision medicine in General Practice, Cardiology, Oncology, Psychiatry, Neurology, Paediatrics, and beyond.
FlahyLife (Foundational Health)
DNA-based screening to reveal susceptibilities and guide personalized prevention, supported by FlahyAI and a drug passport for safe & effective care when needed. (flahyhealth.com ↗︎)
FlahyNG, FlahyNeuro, & FlahyClarity
For personalized medication pathways and translating genetic signals into clinician-guided next steps for precision neurology & psychiatry.
FlahyCX
For genomics based treatment personalization in cardiac health.
FlahyPX
For genomics based care in paediatrics, and rare disease screening.
FlahyOX, FlahyOX-G, & FlahyRecovery
Genomics and Transcriptomics integrated into treatment decisions for precision oncology and clinical trial matching.
Leadership
Jagjit Singh
Founder & Chief Executive Officer
Advisory Board
Christopher Mason
Raul Rabadan
Andrew Blumberg
Kaja Wasik
Arun Goyal